Several significant new injectable cancer drugs are now hitting the market

Several significant new injectable cancer drugs are now hitting the market...with more on the way. The FDA is accelerating approval of important cancer drugs...similar to AIDS drugs.

Lilly is now marketing Gemzar (GEM-zar, gemcitabine), the first new drug for advanced pancreatic cancer in 30 years.

It's an alternative to 5-fluorouracil and reduces pain better.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote